Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pacific Biosciences (NQ: PACB )

5.580 -0.160 (-2.79%)
Streaming Delayed Price Updated: 10:59 AM EDT, May 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,128,291
Open 5.610
Bid (Size) 5.570 (33)
Ask (Size) 5.580 (8)
Prev. Close 5.740
Today's Range 5.425 - 5.670
52wk Range 4.510 - 36.36
Shares Outstanding 224,383,347
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Piper Sandler Maintains Neutral Rating for Pacific Biosciences: Here's What You Need To Know
Piper Sandler has decided to maintain its Neutral rating of Pacific Biosciences (NASDAQ:PACB) and lower its price target from $13.00 to $6.00. Shares of Pacific Biosciences are trading down 2.74% over... 
Via Benzinga
Pacific Biosciences Clocks 14% Jump In Q1 Revenues
 
Via Benzinga

Performance

YTD
-73.28%
-73.28%
1 Month
-22.39%
-22.39%
3 Month
-45.93%
-45.93%
6 Month
-75.40%
-75.40%
1 Year
-78.36%
-78.36%

More News

Read More
Recap: Pacific Biosciences Q1 Earnings
Via Benzinga
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
Via Talk Markets
Lessons For Elon Musk: 5 Notorious Failed Hostile Takeovers
Via Benzinga
Pacific Biosciences Shares Fall As Q4 Earnings Miss Estimates
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
How do Biotechnology Funds and ETFs Perform Over Five Years?
Via Talk Markets
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Via Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Recap: Pacific Biosciences Q4 Earnings
Via Benzinga
The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Via Benzinga
Earnings Scheduled For February 15, 2022
Via Benzinga
Bionano Is Not the Genomics Stock To Bet On
Via InvestorPlace
48 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 150 Points; Accolade Shares Spike Higher
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
Via Talk Markets
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 3.5%; Pacific Biosciences of California Shares Fall
Via Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.